4 Background: Adherence in the context of patients with acute conditions is a major public health issue.
1 The notion of adherence uniquely to prescriptions for medication is insufficient [27, 28] . Although 2 some authors defined adherence "as the extent to which a patient's behaviour (in terms of taking 3 medication, following a diet, modifying habits, or attending clinics) coincides with medical or health 4 advice" [4] , there is still no method to measure adherence that includes all aspects of a patient's 5 behaviour after a consultation. There lacks a standardized tool that is well adapted to clinical research 6 [29] and assessment of health-care quality [1, 17] , and none suitable for the context of AC [30, 31] . The 7 question of how best to measure adherence is still open [2] .
8 A generic scale would be useful to analyse the relationship of between adherence to and other 9 outcomes such as Doctor-Patient Communication (DPC) or satisfaction, and to quantify and compare 10 the impact of measures introduced to improve adherence, such as Patient information leaflets [30, 31] . 11 12 Our objective was to create a Global Adherence Scale usable in the context of an Acute Condition
(GASAC) based on a theoretical model describing the various dimensions of patient behaviour
14 following a consultation [15] and the results of a literature search. Then, to validate it in two hospital 15 emergency departments and analyse its determinants. 16 17 Materials and methods 18 Literature search 19 We searched the Medline database using the following Mesh terms: patient compliance, adherence 20 AND scale, tool, assessment, measures or questionnaires, in various combinations. We also consulted 21 the Embase and PsycInfo databases, and the Cochrane library in English.
22 Our search filter covered the period from 1985 to 2014. Only meta-analyses, randomized controlled 23 trials, and reviews of the literature were retained. In addition we searched English (NHS) and US 24 (Agency for Healthcare Research and Quality, AHRQ) institutional databases on quality of care 25 assessment and books on the field. Two doctors independently screened titles and if necessary abstracts 26 for all types of articles pertinent to adherence in the context of acute conditions. A manual search was 1 also conducted from the bibliographies of promising articles. Since our literature search did not find 2 specific articles for AC, we based the elaboration of our scale on: 1/ a previously constructed 3 theoretical model, itself based on the literature, 2/ commonly used definitions of adherence [2, 4] The pilot study 7 The first version was tested in a pilot study on 30 patients whatever the pathology diagnosed.
8 Immediately after the consultation the patient was given the questionnaire to complete, followed by an 9 additional page about their understanding of the questionnaire and open remarks. 10 
11
Sample size calculation 12 We based our calculation on the general adherence literature according to a systematic Cochrane 13 Library review [27] . To measure the impact of any intervention on adherence we needed to obtain a 14 minimum of 75 completed questionnaires for each group. As we intended to include patients with 15 either a non-severe trauma i.e. ankle sprain, or a medical indication i.e. an infection, this meant the 16 minimum sample size for our study was 150. 22 Allowing for 20% patients potentially being lost to follow-up we required 180 patients in total. We 23 stopped inclusions when this number was reached. 
4
5 Physicians who regularly worked in the ED of the two establishments were contacted and voluntarily 6 participated. The physician briefly presented the study (orally and in a patient information letter) and 7 proposed participation to all consecutive adults and children (>15 and accompanied by an adult) 8 diagnosed with a common traumatic or infectious acute condition (ankle sprain or infectious colitis, 9 pyelonephritis, diverticulitis, prostatitis or pneumonia). These acute conditions were chosen from those 10 most commonly seen in primary care [22] and which usually require medication, prescriptions for 11 specialist evaluation or tests, and/or advice and follow-up instructions. We excluded patients whose 12 care led to a hospital stay of more than 48 hours.
13
14 The patient information letter explained the broad aims of the study: to help develop tools to measure 15 the quality of care. Details were not given so as to reduce any self-selection bias. If the patient agreed 16 to participate, they signed a written informed consent. If they declined to participate, this was recorded.
17 Physicians included patients in the study by completing a short inclusion-case report form, describing 18 the patient's baseline and socio-demographic characteristics.
19 Patients were contacted by telephone between 7 and 10 days after the consultation by a study 20 investigator who did not participate in patient recruitment. They were asked the series of questions 21 from the Girerd scale (yes/no) and then the GASAC questions (scored on a Likert scale of 1 to 4). Next 22 they were asked a series of questions about DPC, about patient satisfaction and some additional 23 questions about the intentional or non-intentional nature of their behaviour (not counted in the score).
24
Statistical analysis 25 Statistical analysis was performed using Stata Version 13.0 (Stata Corp, College Station, Texas).
26 Statistical tests were performed with a significance level of 0.05. Qualitative variables are described by 27 frequency and percentages, and quantitative variables using medians and IQR [25th and 75th
28 percentiles]. The internal consistency of the GASAC score items was assessed by Cronbach's alpha 1 [34] . For quantitative variables, we used the Mann-Whitney test to compare two groups, or the 2 Kruskal-Wallis test to compare more than two groups (non-parametric tests). For qualitative variables, 3 we used the Chi-squared test. Finally, we conducted a multivariate logistic regression to identify 4 factors associated with a "high" adherence according to the distribution of the histogram. To study the 5 determinants of adherence we had to dichotomise the variables, so patients with a GASAC score ≥ 0.8 6 were classed as "highly-adherent", whereas those with a score < 0.8 were classed as "poorly-adherent".
7 All patient characteristics, the level of information, satisfaction and DPC score with p<0.2 in univariate 8 analysis were included into the full model. The final model was obtained by a manual step-wise 9 logistic regression. The correlation between GASAC and the DPC, and correlation between subscales 10 of GASAC scores was explored by calculating Spearman's rho.
11

Results
12 Literature search 13 Our search extracted 845 records, including 80 reviews. Among these, neither of the two doctors found 14 any reviews or original articles that dealt with an acute condition, nor with global adherence.
15 Concordance was 100%. Among the reviews, four dealt with adherence to exercises (e.g. for 16 musculoskeletal disease); one with showing up at a mammography appointment and one with keeping 17 to a diet. The rest concerned drug adherence in chronic diseases (HIV, psychiatric disease, diabetes).
18 Due to the lack of specific articles we consulted those dealing with adherence from a general point of 19 view, non-specific to any given disease, and searched their bibliographies manually. We used scales 20 measuring the quality of care from articles, the institutional websites and books [32] [33] [34] [35] [36] . Thus while the 21 literature did not provide us with any suitable scales it helped us to be more precise and to better 22 formulate our questions. We profited from the accumulated knowledge of the multidisciplinary 23 research team that included experts in "adherence" (AG, BA).
24
25 Description of the new scale 1 GASAC incorporates four adherence subscales: drug prescriptions (3 items); laboratory tests and/or 2 radiography prescriptions (one item); lifestyle advice (one item) and instructions on when, or if, to 3 consult a medical professional again (one item). These 6 items were each rated from 1 to 4 (1 = no, 2 = 4 rather not, 3 = rather yes, 4 = yes). As not all questions were relevant to all patients (not all patients 5 received prescriptions and /or instructions) the final score was expressed as the ratio, between 0 and 1, 6 of the patient's answers to the questions actually posed by the study investigator and the maximum 7 possible score from this number of questions (Table 1 ). The mean time to complete the questionnaire 8 was 3 minutes. Figure 1 shows the patient flow chart.
8 Figure 1 . Flow-diagram for the validation of the GASAC scale. Patients lost to follow-up were those 9 who could not be contacted by telephone after 3 attempts.
10 Table 3 shows the baseline and socio-demographic characteristics of the patients. 11 12 
External validity of the GASAC questionnaire
14 We compared the GASAC and Girerd scores (Figure 2 ). The Girerd analysis included 149 patients with 15 scores distributed as follows: no patient had a score of less than 3/6; 5 (3.3%) had a score of 3/6; 19
16 (12.8%) had a score of 4/6; 35 (23.5%) had a score of 5/6 and 90 (60.4%) had a score of 6/6. Using a 17 non-parametric test there was a statistically significant link between the GASAC score and the Girerd 18 score (p<0.01) and between the drug sub-section of the GASAC score and the Girerd score (p<0.01).
19 We also found a statistically significant correlation between the GASAC and satisfaction scores (n= The determinants of adherence 9 Using an univariate analysis, we determined that the variables associated (p<0.05) with high adherence 10 were the age-band over 40 years, an infectious pathology (as compared to trauma), high patient 11 satisfaction and a high DPC score. 
